Scope Law advises a Swiss medtech company in negotiating the terms of a joint venture agreement with Chinese investors and partners to distribute and commercialize its innovative products and devices for the Chinese market.
top of page
Recent Posts
See AllScope Law acts as Swiss legal counsel to the sole shareholder and managing director of NCD Ingredients GmbH (Germany) on the sale of all...
Scope Law acts as Swiss legal counsel to the NASDAQ-listed global marketing and communications leader Stagwell, Inc. (USA) in its...
Scope Law advises Perovskia Solar AG , Aubonne, a spin-off from the Swiss Federal Laboratories for Materials Science and Technology (...
bottom of page
Comments